Stockreport

Incyte marks late-stage trial win for Xencor-partnered lymphoma therapy [Seeking Alpha]

Xencor, Inc.  (XNCR) 
Last xencor, inc. earnings: 2/24 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.xencor.com/investor-relations
PDF developed with Xencor ( XNCR ), setting up a potential label expansion for the drug as a first-line option against a type of non-Hodgkin lymphoma. Citing Newsletters [Read more]